Comparison of Nicotinamide Treatments for Actinic Keratosis

PHASE1CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions
Actinic Keratoses
Interventions
DRUG

Oral Nicotinamide

"Participants from group 1 received 120 capsules of 500 mg nicotinamide and a tube of placebo cream at each visit. . All participants were instructed to take 1 capsule every 12 hours and to apply the cream to their entire face twice a day.~Participants were unaware of which group they were allocated to and participants in both groups received either capsules (active or placebo, which looked identical) or a tube of cream (active or placebo, which looked identical). In follow-up visits participants returned empty tubes to the responsible pharmacist.~At the initial assessment and at 6 months photographs of the participants' faces were taken."

DRUG

topical nicotinamide

"Participants from group 2 received a tube of 5% nicotinamide cream and 120 placebo capsules. All participants were instructed to take 1 capsule every 12 hours and to apply the cream to their entire face twice a day.~Participants were unaware of which group they were allocated to and participants in both groups received either capsules (active or placebo, which looked identical) or a tube of cream (active or placebo, which looked identical). In follow-up visits participants returned empty tubes to the responsible pharmacist.~At the initial assessment and at 6 months photographs of the participants' faces were taken."

Trial Locations (1)

90035003

Programa de Pós Graduação Ciencias Médicas UFRGS, Porto Alegre

All Listed Sponsors
collaborator

Univates

OTHER

lead

Federal University of Rio Grande do Sul

OTHER